Loading...
Willow Biosciences Inc.
CANSF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.14
$-0.00(-1.42%)
Willow Biosciences Inc. (CANSF) Financial Performance & Income Statement Overview
Review Willow Biosciences Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
297.78%
↑ 297.78%
Operating Income Growth
54.55%
↑ 54.55%
Net Income Growth
52.50%
↑ 52.50%
Operating Cash Flow Growth
65.91%
↑ 65.91%
Operating Margin
-131.36%
↓ 131.36%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-132.75%
↓ 132.75%
ROE
-2099.75%
↓ 2099.75%
ROIC
-1234.68%
↓ 1234.68%
Willow Biosciences Inc. (CANSF) Income Statement & Financial Overview
Review Willow Biosciences Inc.'s (CANSF) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $1.88M | $1.70M | $1.03M | $51000.00 |
Cost of Revenue | -$705000.00 | $0.00 | $353000.00 | $352000.00 |
Gross Profit | $2.59M | $1.70M | $673000.00 | -$301000.00 |
Gross Profit Ratio | $1.37 | $1.00 | $0.66 | -$5.90 |
R&D Expenses | $1.30M | $1.42M | $1.23M | $1.11M |
SG&A Expenses | $869000.00 | $997000.00 | $889000.00 | $1.04M |
Operating Expenses | $3.29M | $2.73M | $2.48M | $2.15M |
Total Costs & Expenses | $2.94M | $2.73M | $2.48M | $2.51M |
Interest Income | $68000.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $131000.00 | $52000.00 | $47000.00 | $33000.00 |
Depreciation & Amortization | $367000.00 | $314000.00 | $353000.00 | $352000.00 |
EBITDA | -$754000.00 | -$715000.00 | -$1.10M | -$1.97M |
EBITDA Ratio | -$0.40 | -$0.42 | -$1.07 | -$38.65 |
Operating Income | -$1.06M | -$1.03M | -$1.45M | -$2.46M |
Operating Income Ratio | -$0.56 | -$0.60 | -$1.41 | -$48.16 |
Other Income/Expenses (Net) | -$63000.00 | -$52000.00 | -$47000.00 | -$33000.00 |
Income Before Tax | -$1.25M | -$1.08M | -$1.50M | -$2.36M |
Income Before Tax Ratio | -$0.67 | -$0.63 | -$1.46 | -$46.20 |
Income Tax Expense | -$354000.00 | $165000.00 | $190000.00 | $2000.00 |
Net Income | -$898000.00 | -$1.25M | -$1.69M | -$2.36M |
Net Income Ratio | -$0.48 | -$0.73 | -$1.64 | -$46.24 |
EPS | -$0.009 | -$0.009 | -$0.01 | -$0.02 |
Diluted EPS | -$0.009 | -$0.009 | -$0.01 | -$0.02 |
Weighted Avg Shares Outstanding | $134.54M | $141.14M | $127.25M | $125.44M |
Weighted Avg Shares Outstanding (Diluted) | $134.54M | $141.14M | $127.25M | $125.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan